SARM1 is responsible for calpain-dependent dendrite degeneration in mouse hippocampal neurons
暂无分享,去创建一个
T. Miyamoto | M. Larhammar | J. Dugas | Joseph W. Lewcock | A. Bagdasarian | Chaeyoung Kim | Arun P. Thottumkara | M. Calvert | Johann Chow | Jack D. DeGroot | Lesley Kane | Brian M Fox | Lesley A Kane
[1] J. Gilley,et al. NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapies , 2023, Neuroscience Research.
[2] J. Milbrandt,et al. Shared TIR enzymatic functions regulate cell death and immunity across the tree of life , 2022, Science.
[3] P. Thompson,et al. The chemical biology of NAD+ regulation in axon degeneration. , 2022, Current opinion in chemical biology.
[4] Labchan Rajbhandari,et al. Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons , 2022, Neurobiology of Disease.
[5] Yang Cai,et al. A Conformation-specific Nanobody Targeting the NMN-activated State of SARM1 , 2022, bioRxiv.
[6] A. Sarkar,et al. Phagocytosis and self-destruction break down dendrites of Drosophila sensory neurons at distinct steps of Wallerian degeneration , 2022, Proceedings of the National Academy of Sciences.
[7] J. Milbrandt,et al. Sarm1 activation produces cADPR to increase intra-axonal Ca++ and promote axon degeneration in PIPN , 2021, The Journal of cell biology.
[8] Yong Q. Zhang,et al. The calcium-dependent protease calpain in neuronal remodeling and neurodegeneration , 2021, Trends in Neurosciences.
[9] J. Milbrandt,et al. Live imaging reveals the cellular events downstream of SARM1 activation , 2021, bioRxiv.
[10] L. Hartley-Tassell,et al. SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration , 2021, Neuron.
[11] Yang Cai,et al. Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate , 2021, bioRxiv.
[12] A. Hoke,et al. Cisplatin induced neurotoxicity is mediated by Sarm1 and calpain activation , 2020, Scientific Reports.
[13] Y. Shkolnisky,et al. Structural basis for SARM1 inhibition and activation under energetic stress , 2020, eLife.
[14] Q. Chang,et al. The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative SARM1 , 2020, Nature.
[15] A. Yaron,et al. The Structural Basis for SARM1 Inhibition, and Activation Under Energetic Stress , 2020, bioRxiv.
[16] Sean P. Brown,et al. Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1. , 2020, Cell reports.
[17] A. Höke,et al. Programmed axon degeneration: from mouse to mechanism to medicine , 2020, Nature Reviews Neuroscience.
[18] T. Engber,et al. Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration. , 2020, Trends in pharmacological sciences.
[19] T. Engber,et al. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons , 2020, Experimental Neurology.
[20] P. Thompson,et al. Initial Kinetic Characterization of Sterile Alpha and Toll/Interleukin Receptor Motif-Containing Protein 1. , 2020, Biochemistry.
[21] Weili Tian,et al. Systemic loss of Sarm1 protects Schwann cells from chemotoxicity by delaying axon degeneration , 2020, Communications Biology.
[22] Hon Cheung Lee,et al. Resolving the topological enigma in Ca2+ signaling by cyclic ADP-ribose and NAADP , 2019, The Journal of Biological Chemistry.
[23] Bostjan Kobe,et al. NAD+ cleavage activity by animal and plant TIR domains in cell death pathways , 2019, Science.
[24] A. Whitworth,et al. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration , 2019, Neurobiology of Disease.
[25] Zhengshuang Xu,et al. A Cell-Permeant Mimetic of NMN Activates SARM1 to Produce Cyclic ADP-Ribose and Induce Non-apoptotic Cell Death , 2019, iScience.
[26] G. Bartolucci,et al. Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites. , 2018, Cell chemical biology.
[27] J. Milbrandt,et al. The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration , 2017, Neuron.
[28] Kevin W. Eliceiri,et al. ImageJ2: ImageJ for the next generation of scientific image data , 2017, BMC Bioinformatics.
[29] R. Menna-Barreto,et al. Why calpain inhibitors are interesting leading compounds to search for new therapeutic options to treat leishmaniasis? , 2016, Parasitology.
[30] H. Sorimachi,et al. Calpain research for drug discovery: challenges and potential , 2016, Nature Reviews Drug Discovery.
[31] J. Milbrandt,et al. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion , 2016, eLife.
[32] J. Milbrandt,et al. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism , 2016, Neuron.
[33] M. Gering,et al. Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca(2+) Influx but Only Modestly Influenced by Mitochondria. , 2015, Cell reports.
[34] M. Tessier-Lavigne,et al. Live Imaging of Calcium Dynamics during Axon Degeneration Reveals Two Functionally Distinct Phases of Calcium Influx , 2015, The Journal of Neuroscience.
[35] A. Guse. Calcium mobilizing second messengers derived from NAD. , 2015, Biochimica et biophysica acta.
[36] R. Ribchester,et al. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration , 2014, Cell Death and Differentiation.
[37] J. Milbrandt,et al. Mitochondrial Dysfunction Induces Sarm1-Dependent Cell Death in Sensory Neurons , 2014, The Journal of Neuroscience.
[38] N. Renier,et al. Regulation of Axon Degeneration after Injury and in Development by the Endogenous Calpain Inhibitor Calpastatin , 2013, Neuron.
[39] Catherine A. Collins,et al. Sodium and Potassium Currents Influence Wallerian Degeneration of Injured Drosophila Axons , 2013, The Journal of Neuroscience.
[40] J. Milbrandt,et al. Sarm1-Mediated Axon Degeneration Requires Both SAM and TIR Interactions , 2013, The Journal of Neuroscience.
[41] R. Neumar,et al. Calpains mediate axonal cytoskeleton disintegration during Wallerian degeneration , 2013, Neurobiology of Disease.
[42] D. O'Leary,et al. A Caspase Cascade Regulating Developmental Axon Degeneration , 2012, The Journal of Neuroscience.
[43] Mary A. Logan,et al. dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway , 2012, Science.
[44] L. Zhang,et al. Studies of the Synthesis of Nicotinamide Nucleoside and Nucleotide Analogues and Their Inhibitions Towards CD38 NADase. , 2012 .
[45] Zhenjun Yang,et al. Studies on the Synthesis of Nicotinamide Nucleoside and Nucleotide Analogues and Their Inhibitions towards CD38 NADase , 2011 .
[46] M. Rolls,et al. Dendrites Have a Rapid Program of Injury-Induced Degeneration That Is Molecularly Distinct from Developmental Pruning , 2011, The Journal of Neuroscience.
[47] R. Ribchester,et al. Targeting NMNAT1 to Axons and Synapses Transforms Its Neuroprotective Potency In Vivo , 2010, The Journal of Neuroscience.
[48] J. Gilley,et al. Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons , 2010, PLoS biology.
[49] J. Milbrandt,et al. Transgenic Mice Expressing the Nmnat1 Protein Manifest Robust Delay in Axonal Degeneration In Vivo , 2009, The Journal of Neuroscience.
[50] R. Ribchester,et al. WldS protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice , 2009, The Journal of cell biology.
[51] T. O'Connor,et al. Neurite consolidation is an active process requiring constant repression of protrusive activity , 2009, The EMBO journal.
[52] Q. Hogan,et al. Contribution of Calcium Channel Subtypes to the Intracellular Calcium Signal in Sensory Neurons: The Effect of Injury , 2007, Anesthesiology.
[53] H. Kobori,et al. New Generation Calcium Channel Blockers in Hypertensive Treatment. , 2006, Current hypertension reviews.
[54] J. Milbrandt,et al. Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration , 2004, Science.
[55] V. Perry,et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene , 2001, Nature Neuroscience.
[56] J. Kocsis,et al. Voltage-gated calcium currents in axotomized adult rat cutaneous afferent neurons. , 2000, Journal of neurophysiology.
[57] Junying Yuan,et al. Specific Cleavage of α-Fodrin during Fas- and Tumor Necrosis Factor-induced Apoptosis Is Mediated by an Interleukin-1β-converting Enzyme/Ced-3 Protease Distinct from the Poly(ADP-ribose) Polymerase Protease* , 1996, The Journal of Biological Chemistry.
[58] V. Perry,et al. Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve , 1989, The European journal of neuroscience.
[59] T. Tsujinaka,et al. Synthesis of a new cell penetrating calpain inhibitor (calpeptin). , 1988, Biochemical and biophysical research communications.
[60] P. LeWitt. The neurotoxicity of the rat poison vacor. A clinical study of 12 cases. , 1980, The New England journal of medicine.
[61] J. Geddes,et al. through Increased Mitochondrial Flux and Enhanced Mitochondrial Ca 2+ Buffering , 2012 .
[62] J. Mandell,et al. Compartmentation of alpha-internexin and neurofilament triplet proteins in cultured hippocampal neurons , 1996, Journal of neurocytology.
[63] D. Spyker,et al. Diabetes mellitus associated with autonomic and peripheral neuropathy after Vacor rodenticide poisoning: a review. , 1981, Clinical toxicology.